The Journal of Neuroscience, July 9, 2003, 23(14):6111-6122
Previous Article | Next Article 
Caspase Inhibitors Promote Vestibular Hair Cell Survival and Function after Aminoglycoside Treatment In Vivo
Jonathan I. Matsui,1,4
Asim Haque,4
David Huss,4
Elizabeth P. Messana,5
Julie A. Alosi,5
David W. Roberson,5,6
Douglas A. Cotanche,5,6
J. David Dickman,1,2,3,4 and
Mark E. Warchol1,2,3,4
1Division of Biology and Biomedical Sciences,
Program in Neurosciences, 2Department of Anatomy and
Neurobiology, 3Department of Otolaryngology,
Washington University in St. Louis, St. Louis, Missouri 63110,
4Harold W. Siebens Hearing Research Center, Central
Institute for the Deaf, St. Louis, Missouri 63110,
5Department of Otolaryngology, Children's Hospital
Boston, Boston, Massachusetts 02115, and 6Department
of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts
02115
 |
Abstract
|
|---|
The sensory hair cells of the inner ear undergo apoptosis after acoustic
trauma or aminoglycoside antibiotic treatment, causing permanent auditory and
vestibular deficits in humans. Previous studies have demonstrated a role for
caspase activation in hair cell death and ototoxic injury that can be reduced
by concurrent treatment with caspase inhibitors in vitro. In this
study, we examined the protective effects of caspase inhibition on hair cell
death in vivo after systemic injections of aminoglycosides. In one
series of experiments, chickens were implanted with osmotic pumps that
administrated the pan-caspase inhibitor z-Val-Ala-Asp(Ome)-fluoromethylketone
(zVAD) into inner ear fluids. One day after the surgery, the animals received
a 5 d course of treatment with streptomycin, a vestibulotoxic aminoglycoside.
Direct infusion of zVAD into the vestibule significantly increased hair cell
survival after streptomycin treatment. A second series of experiments
determined whether rescued hair cells could function as sensory receptors.
Animals treated with streptomycin displayed vestibular system impairment as
measured by a greatly reduced vestibulo-ocular response (VOR). In contrast,
animals that received concurrent systemic administration of zVAD with
streptomycin had both significantly greater hair cell survival and
significantly increased VOR responses, as compared with animals treated with
streptomycin alone. These findings suggest that inhibiting the activation of
caspases promotes the survival of hair cells and protects against vestibular
function deficits after aminoglycoside treatment.
Key words: auditory; hair cell; vestibular; apoptosis; caspase inhibitors; vestibular ocular reflex
 |
Introduction
|
|---|
Hair cells are mechanoreceptors in the inner ear that detect sound, head
position, and head movement. Aminoglycoside antibiotics are toxic to hair
cells, and patients treated with large doses of aminoglycosides often incur
permanent vestibular and auditory deficits
(Hinshaw and Feldman, 1945
).
Morphological evidence from many vertebrate species suggests that the loss of
hair cells in response to aminoglycoside treatment occurs via apoptosis
(Jørgensen, 1981
,
1991
;
Forge, 1985
;
Li et al., 1995
;
Forge and Li, 2000
;
Matsui et al., 2002a
).
Neuronal apoptosis is an evolutionarily conserved form of cell death that
occurs through an orderly series of cellular events
(Raff, 1998
) and results in
the activation of caspases, which trigger a proteolytic cascade that leads to
the degradation of the cytoplasmic and nuclear proteins of the cell (for
review, see Salvesen and Dixit,
1997
). Cell-permeable peptides [e.g., the tripeptide
z-Val-Ala-Asp(Ome)fluoromethylketone (zVAD)] can inhibit caspase activation in
various neurons (for review, see Salvesen
and Dixit, 1997
). Although numerous studies have examined the role
of caspase inhibitors in preventing neuronal death in vitro, few
studies have investigated whether the rescued cells remain functional in
vivo. Intracerebroventricular administration of the zVAD, however,
promoted neuronal survival in transgenic mouse models of neurodegeneration
(Ona et al., 1999
;
Li et al., 2000b
), and
behavioral tests implied that the saved neurons were functional.
Previous studies have demonstrated that caspase inhibitors prevent
apoptosis in auditory and vestibular hair cells in vitro
(Liu et al., 1998
;
Forge and Li, 2000
;
Cunningham et al., 2002
;
Matsui et al., 2002a
;
Cheng et al., 2003
). In the
present study, we first determined the effects of caspase inhibition on hair
cell death in vivo by examining hair cell densities in vestibular
organs after systemic injections of aminoglycosides and simultaneous infusion
of caspase inhibitors into the inner ear. Additional experiments quantified
hair cell function after rescue with caspase inhibitors. In all vertebrates,
head motion produces hair cell responses and compensatory eye movements that
function to stabilize visual gaze (Dickman
and Angelaki, 1999
; Dickman et
al., 2000
). Aminoglycoside treatment in chickens results in
reduced vestibulo-ocular reflex (VOR)
(Carey et al., 1996
) and
vestibulocolic reflex (VCR) (Goode et al.,
1999
,
2001
) responses to rotational
motion. To determine whether rescued semicircular and otolith vestibular hair
cells were functional after combined zVAD and streptomycin treatment, we
measured three-dimensional eye-movement responses for the horizontal VOR
(HVOR) and the off-vertical axis reflex (OVAR), respectively. Treatment with
zVAD provided significant protection from ototoxic insult to both the
vestibular receptors and VOR.
Preliminary reports of portions of these data have been published
previously (Matsui et al.,
2002b
).
 |
Materials and Methods
|
|---|
Two series of experiments were performed. In the first experimental series,
the general caspase inhibitor zVAD was delivered into the inner ear labyrinth.
Chicks also received concurrent streptomycin treatment, and hair cell survival
was examined. In the second experimental series, protection of vestibular
function was examined by measuring the VOR after systemic administration of
zVAD and streptomycin.
Animals
White Leghorn chickens (Gallus domesticus) were obtained from
Charles River SPAFAS (North Franklin, CT) or Ideal Poultry Breeding Farms
(Cameron, TX) and housed at the animal care facilities at either the Beth
Israel Deaconess Hospital (series 1) or the Central Institute for the Deaf
(series 2). Chicks were received at 314 d of age and observed for
718 d to ensure that they were healthy. Surgeries were performed at 21
d of age. All experimental protocols were approved by the Institutional Animal
Care and Use Committees at the Central Institute for the Deaf, Washington
University in St. Louis, and Children's Hospital Boston and conform to The
Society for Neuroscience and the National Institutes of Health animal use
guidelines.
Experiment series 1: efficacy of zVAD delivery in vivo
Osmotic pump implantation. Chicks were anesthetized using inhaled
isoflurane that was delivered via endotracheal intubation as described by
Roberson et al. (2000b
).
Surgical sites on the head and back were cleaned with a depilatory agent
followed by a biocidal wipe. The post-auricular area was injected with 0.1 cc
of bupivacaine hydrochloride (AstraZeneca) for postoperative anesthetic.
Enrofloxacin (Baytril; Bayer) was given sublingually for antibiotic
prophylaxis. A thermal incision was made behind the left ear revealing the
mastoid process. A portion of the mastoid bone was removed to expose the
anterior semicircular canal and the surface of the anterior ampulla. A
stainless steel cannula from a brain infusion kit (outer diameter 0.36 mm;
DURECT Corporation, Cupertino, CA) was modified so that the infusion cannula
was inserted into a flexible plastic tube until the cannula tip projected out
1 mm (Roberson et al.,
2000a
). The cannula was placed in a fistula created in the
vestibule postero-superior to the anterior ampulla and secured with dental
acrylic.
An osmotic pump (model 2002, 0.5 µl/hr; DURECT Corporation) was filled
with 200 µl of either 50 or 100 µM zVAD (Enzyme Systems
Products, Livermore, CA) or 0.01% DMSO dissolved in saline (carrier). We chose
to use zVAD in our studies because previous evidence suggested that the drug
had a long half-life (Ona et al.,
1999
; Li et al.,
2000b
) and that zVAD promoted vestibular hair cell survival in
vitro (Matsui et al.,
2002a
). The pump was placed in a subcutaneous pocket created on
the animal's back and connected to the cannula via a plastic catheter tunneled
under the skin. Care was taken to ensure that there were no air bubbles in the
tubing or pump. The incisions over the back and ear were closed with nylon
suture.
Streptomycin treatment. Animals received daily intramuscular
injections of either streptomycin (1200 mg/kg; Sigma, St. Louis, MO) or saline
for 3 or 5 d, beginning 1 d after the osmotic pump surgery. Streptomycin
sulfate was chosen because it preferentially causes lesions within the
striolar region of the chick utricle both in vivo (Weisleder and
Rubel, 1992
,
1993
) and in vitro
(Matsui et al., 2000
) and not
in the auditory organ, the basilar papilla. Age-matched chicks received saline
injections and served as controls. One day after the last drug treatment, the
animals were killed, and the utricles were removed from the pump-implanted ear
and placed into 4% paraformaldehyde for 20 min followed by buffer rinse and
storage in PBS for later calretinin immunohistochemistry processing (see
below).
Experiment series 2: physiological testing of vestibular
function
Head stud implantation. For three-dimensional eye-movement
recordings, a head stud was implanted in each bird so that the horizontal
semi-circular canals were parallel to the earth vertical axis (EVA) rotation
plane. Animals were anesthetized with isoflurane, and an incision was made
along the midline of the skull. A specially designed head stud (square
aluminum tubing) was secured to the skull using stainless steel screws and
dental acrylic mixed with ampicillin (5%) powder. The skin was approximated to
the acrylic cap and secured with cyanoacrylate glue (Vetbond Tissue Adhesive).
After surgery, a single dose of buprenorphin hydrochloride (Buprenex; 10
mg/kg) was administered for postoperative analgesia, and enrofloxacin was
given as a prophylactic antibiotic. Animals were then returned to the animal
facility to recover.
Eye coil implantation. Three-dimensional eye movements were
recorded from the left eye using a three-field coil system (CNC Engineering,
Seattle, WA) and a dual-search coil
(Robinson, 1963
). The
three-field coil system was secured to a servo-controlled three-axis rotator
system that was mounted on a linear sled (Neurokinetics, Pittsburgh, PA). The
dual-search coil consisted of two miniature 80-turn watch-maker coils that
were glued orthogonally to each other
(Hess and Dieringer, 1991
),
with cyanoacrylate glue applied to the base of the coil to form a
"contact lens." Proparacaine hydrochloride (0.5% Bupivicaine) was
topically applied to the cornea of the eye, and the dual-search coil was
placed on the corneal surface. A small drop of tissue glue was administered to
the contact lens before placement on the eye to eliminate slippage
(Hess, 1990
;
Hess and Dieringer, 1991
;
Dickman and Angelaki,
1999
).
After testing, the animal was removed from the rotator, proparacaine
hydrochloride was again applied to the cornea, and the search coil was removed
with a saline rinse. The cornea was then treated with a neomycin/bacitracin
ophthalmic ointment. Occasionally during the experimental procedure the coil
became displaced from the cornea. This was immediately apparent in the
oscilloscope traces because saccades and post-saccadic oscillations were
absent. When this occurred, the experimental session was stopped, and the data
were discarded.
Experimental and stimulation procedure. All experiments were
performed with awake animals placed in the dark to eliminate visual cues.
Animals were restrained by wrapping an elastic bandage around the wings and
body, placed into a foam padded body holder, and attached to the motion
delivery system using the implanted head stud. The head was centered in the
magnetic field with the major plane of the horizontal semicircular canals
oriented parallel to the EVA rotation plane. All stimulus waveforms were
produced with a microcomputer and a peripheral interface (1401 plus; Cambridge
Electronic Design, Cambridge, UK) using custom script files written for
simultaneous stimulus delivery and data acquisition. Eye-position signals were
amplified, filtered, and recorded on-line (digitized rate of 833 Hz).
Spontaneous eye movements were recorded with animals stationary while objects
of interest moved through the visual field. These eye movements were analyzed
to produce a primary position vector that served as a calibration point for
subsequent evoked responses. Sinusoidal EVA rotations were delivered to elicit
HVOR responses. Frequencies ranged between 0.01 and 2 Hz and were delivered at
a constant peak velocity of 20°/sec, except for the 2 Hz stimulus, which
was mechanically limited to 10°/sec. OVAR stimulation consisted of
constant velocity rotation, in both the clockwise (CW) and counterclockwise
(CCW) directions, about an axis that was tilted 11.5° away from earth
vertical. OVAR rotations ranged from 0.0278 to 0.333 Hz. The OVAR stimulus
produced a resultant linear acceleration vector of 0.2 x g,
which was sinusoidally modulated relative to the otolith organ receptor as the
animal was rotated 360°. All animals had normative HVOR and OVAR responses
recorded at posthatch day 28, before other experimental manipulations, so that
each animal could serve as its own control. Each animal was then assigned to
one of four treatment groups (see below). After 5 d of drug treatment, each
animal was again tested for HVOR and OVAR responses on posthatch day 33. Thus,
all animals were age matched to eliminate developmental response
differences.
Systemic treatment with zVAD and streptomycin. Animals that were
being tested for vestibulo-ocular responses received systemic daily injections
for 5 d of (1) zVAD (1.5 mg/kg) and streptomycin (1200 mg/kg), (2)
streptomycin alone, (3) zVAD alone, or (4) saline, beginning 1 d after the
normative eye movements were recorded. We chose to inject the animals with the
zVAD as opposed to implanting the animals with osmotic pumps for two reasons.
First, it was of interest to determine whether systemic administration of zVAD
resulted in a protective effect. Second, we wanted to reduce the possibility
of vestibular dysfunction caused by violating the vestibule with a surgical
cannula. One day after the last drug treatment (posthatch day 33), HVOR and
OVAR responses were obtained. The animals were then anesthetized with 20 mg/kg
sodium pentobarbital (Nembutal) and 20 mg/kg ketamine hydrochloride (Ketaset)
and placed in a stereotaxic frame. A midline incision was made over the
occipital bone, and the horizontal and posterior canals were exposed. The
canals were fenestrated and the left ear was perfused with an aldehyde
solution composed of 3% glutaraldehyde, 2% paraformaldehyde, and 1% acrolein
in 0.1 M sodium cacodylate buffer so that the tissue could be
processed for scanning electron microscopy. The right ear was perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer for 2030 min so
that the tissue could be processed for calretinin immunohistochemistry. The
semicircular canal ampullas and otolith maculae were dissected free and placed
in buffer. The otoconia were removed from the utricle and saccule using a
stream of buffer from a syringe. The left endorgans were stored in fixative
overnight at 4°C, whereas the right endorgans were stored in PBS at
4°C.
Tissue processing
Calretinin labeling. To quantitatively assess the extent of hair
cell survival, hair cells were identified using an antibody for calretinin
(see Fig. 1 A)
(Rogers, 1989
). All
immunohistochemistry occurred at room temperature with thorough PBS washes
between them, unless noted otherwise. Fixed specimens were incubated in 90%
methanol with 0.03% H2O2 for 20 min, followed by
incubation in a blocking solution consisting of PBS, 2% normal horse serum
(NHS), 1% BSA, and 0.2% Triton X-100 for 2 hr. The tissue was then placed
immediately into a rabbit anti-calretinin primary antibody (1:2000, in PBS/2%
NHS; Chemicon, Temecula, CA) and incubated overnight at 4°C. The next day,
inner ear sensory organs were incubated in biotinylated goat anti-rabbit IgG
antibody (1:150, in PBS/0.1% NHS; Vector Laboratories, Burlingame, CA) for 2
hr, followed by avidinbiotinhorseradish peroxidase complex
(Vector Laboratories) for 90 min. Specimens were then reacted with DAB (Vector
Laboratories) for 5 min and mounted on microscope slides in glycerol/PBS
(9:1).

View larger version (43K):
[in this window]
[in a new window]
|
Figure 1. Direct infusion of zVAD into the vestibule promotes hair cell survival
after concurrent treatment with streptomycin sulfate. A,
Photomicrograph of hair cells stained for calretinin immunohistochemistry
after treatment with 100 µM zVAD and 5 d of streptomycin (1200
mg/kg). B, Photomicrograph of calretinin-labeled hair cells after
treatment with the carrier and streptomycin. C, Mean hair cell counts
(±SEM) for the striolar and extrastriolar regions of the utricle after
treatment with saline, streptomycin alone, carrier plus streptomycin, or 50
and 100 µM zVAD and streptomycin treatment. D, Mean
hair cell counts for control, saline, carrier alone, 50 µM zVAD
alone, or 100 µM zVAD alone treated animals. Calretinin-labeled
cells were quantified in 10,000 µm 2 regions of both the
extrastriolar (6 regions per organ) and striolar (4 regions per organ) areas.
n = 68 organs.
|
|
Scanning electron microscopy. To assess hair cell survival in
treated and control animals, left ear endorgans from VOR animals were
processed for scanning electron microscopy. Endorgans were dehydrated in
serial acetone washes (70, 90, 95, 100, 100%), followed by two washes in
tetramethylsilane (Electron Microscopy Services, Fort Washington, PA), and
placed in a 37°C oven to sublimate. The tissue was then mounted on
aluminum studs, sputter-coated with palladium, and subsequently viewed on a
Hitachi 2600 scanning electron microscope at 2025 kV.
Data analysis
Counts of calretinin-labeled cells. Whole-mount preparations were
examined using video microscopy and a Zeiss Axiovert 135 microscope. Cell
counts were made directly from a video monitor using a 100 x 100 µm
calibrated template. Two types of hair cells, designated type I and type II,
are present in the vestibular organs and can be differentiated on the basis of
morphology and innervation (Wersäll,
1956
; Jørgensen and Christensen, 1989). Type I hair cells
are located in the central region of the horizontal canal and the striolar
region of the utricular and saccular maculas. Type II hair cells are found
throughout the crista and macula (Jørgensen and Christensen, 1989;
Si et al., 2003
). Antibodies
recognizing calretinin selectively label both types of hair cells in the chick
vestibular system (Rogers,
1989
; Matsui et al.,
2002a
). In the utricle, calretinin-labeled cells were counted from
six regions in the extrastriolar region and in four striolar regions. In the
saccule, calretinin-labeled cells were counted from three regions in both the
extrastriola and striola. In the horizontal canal, calretinin-labeled cells
were counted from two different central regions. All counting was performed by
an investigator blinded to the treatment group. Care was taken to avoid the
lateral limits of the sensory epithelium because these regions occasionally
contained areas of epithelial damage resulting from the surgical dissection.
The regions were averaged to obtain an estimate of the number of surviving
hair cells per 10,000 µm 2 for each specimen.
Counts of stereocilia bundles. We used previously published
methods to quantify stereocilia bundles in scanning electron micrographs of
the avian vestibular organs (Dye et al.,
1999
). Three horizontal canals and utricles from each treatment
group were studied. Within each organ, three regions of the sensory epithelium
were photographed at a magnification of 1250x. The numbers of
stereocilia bundles in one striolar and two extrastriolar regions were
quantified from each utricle. The striolar region was identified in the normal
animals by the reversal of the stereocilia bundle morphological polarization.
The reversal line was placed into the center of the field for quantification.
Stereocilia bundles within a specified 7500 µm 2 rectangular
window were counted. For immature hair cells, the identification of a
kinocilium was required so that the cells could be counted. The hair cell
counts for each region within each treatment group were then normalized to
10,000 µm 2 and averaged.
HVOR data analysis The three-dimensional eye-position signals and
primary position search coil calibration values were used to express the eye
movement responses as rotation vectors (Ehorz,
Ever, and Etor) in head coordinates
(Haustein, 1989
;
Van Optstal, 1993
). Positive
eye movements were defined as leftward (horizontal), downward (vertical), and
upper pole rotation to the right (clockwise) relative to the standard head
reference frame. The eye position vectors were then desaccaded (including
post-saccadic oscillations) using a semi-automated program (MATLAB) that
allows user validation and manual adjustment of the rejection window. The
desaccaded eye position vectors were differentiated to produce eye velocity
vectors (dE/dt). From the position vectors (E) and velocity
vectors (dE/dt), an angular eye velocity
vector with components
hor,
ver, and
tor, in
head-fixed coordinates was calculated
(Hepp, 1990
) as
=
2(dE/dt + (E x dE/dt))/(1 + E 2).
Once the angular velocity components were derived, each component was
averaged over multiple stimulus cycles (330, depending on frequency),
and the averaged traces were fit with a sine curve using a least-squares
algorithm (MATLAB). The fitted mean sine curves were used to calculate gain
and phase values for horizontal, vertical, and torsional angular eye velocity
components. Gain was expressed as the ratio of peak angular eye velocity to
peak rotation velocity. Phase was expressed as the difference (degrees)
between peak angular eye velocity and peak rotation velocity.
OVAR data analysis. For the OVAR data, the desacadded mean eye
position values for the horizontal, vertical, and torsional eye-movement
components were determined from the least-squares fit to the averaged
responses obtained from multiple stimulus cycles (410, dependent on
frequency) using the equation E(t) = Eo
+ Ep cos(
t +
). The mean eye
position was described as the sum of a DC offset position
(Eo) and a modulation term [Ep
cos(
t +
)]. For OVAR stimulation, the modulation term
was elicited as a function of head position relative to gravity (changing
linear acceleration). Each component of slow-phase eye velocity was fit to the
equation
(t) =
v+
p
cos(
t +
') using the least-squares method. The
slow-phase eye velocity was calculated as the sum of the steady-state
"bias velocity" of nystagmus (
V-OVAR) (visually
negligible: <1%) and the modulation slow-phase velocity
[
p cos(
t +
')]. The modulation
sensitivities for OVAR slow-phase velocity were calculated as the ratio of
peak eye velocity (
p in degrees per second) to peak linear
acceleration (g). The modulation phase values were expressed as the
difference (degrees) between peak eye velocity and head linear acceleration.
Estimates of the sensitivity and phase values for OVAR responses were obtained
from rotations in both the CW and CCW directions. Because the sensitivity,
phase, and spatial orientation values for the eye-movement components observed
during OVAR depend on the underlying spatial and temporal properties of the
otolith-ocular responses, a modified procedure similar to that used to
characterize neural response vectors during OVAR was used
(Angelaki, 1992
;
Angelaki and Hess, 1996
). A
detailed description of the procedure has been published previously
(Angelaki and Hess, 1996
;
Dickman and Angelaki, 1999
).
The component response vector sensitivity was defined as the average of the
calculated sensitivities to CW and CCW response vectors ((CW + CCW)/2). The
temporal phase was computed as the angle (degrees) between each of the maximal
response vectors and the direction of the component spatial orientation vector
((CW - CCW)/2).
Statistical analysis
Statistical analyses for hair cell counts were performed using either an
unpaired two-sample t test assuming unequal variances (Excel;
Microsoft Corporation) or a one-way ANOVA (SigmaStat; SPPS Science
Corporation). Post hoc comparisons, when appropriate, used the
TukeyKramer or Scheffe's test. VOR responses were compared using a
multivariable repeated-measures ANOVA (Statistica; StatSoft).
 |
Results
|
|---|
Ototoxic agents can be administered as a series of systemic injections that
produce rapid hair cell loss in the chick vestibular system (Weisleder and
Rubel, 1992
,
1993
). To develop an optimum
dose for these experiments, 2- to 3-week-old chickens received daily
intramuscular injections of 1200 mg/kg streptomycin sulfate for 3 or 5 d.
After 3 d of injections, streptomycin-treated chicks had a noticeable head
tremor. The frequency of the tremor appeared to increase with each successive
day, indicating that the vestibular system was being severely affected by the
aminoglycoside regimen. After either 3 or 5 d of streptomycin treatment, the
utricles were processed for calretinin immunohistochemistry, to label
surviving hair cells (Rogers,
1989
; Matsui et al.,
2002a
). Calretinin labeling was particularly evident in the
stereocilia bundles (Fig.
1A). If the stereocilia bundle was missing, the apical
portion of the remaining hair cell was labeled (data not shown). Utricles
examined after 3 d of streptomycin treatment displayed a 40% reduction in hair
cell density (Table 1). The
density reductions were similar in both the striola (t(10)
= 2.2; p < 0.001) and extrastriolar regions
(t(9) = 2.2; p < 0.001) of the utricular
maculas. Five days of streptomycin treatment resulted in a 50% reduction in
hair cell density in the extrastriolar region (t(16) =
2.1; p < 0.001) and a 60% reduction in the striolar region
(t(13) = 2.2; p < 0.001).
zVAD infusion promotes hair cell survival after aminoglycoside
treatment (experiment series 1)
Hair cell survival after ototoxic insult can be enhanced by treatment with
the general caspase inhibitors Boc-Asp(Ome)fluoromethylketone (BAF) or zVAD
in vitro (Forge and Li,
2000
; Cunningham et al.,
2002
; Matsui et al.,
2002a
; Cheng et al.,
2003
). To determine whether zVAD promoted hair cell survival
in vivo after streptomycin treatment, chickens were implanted with
osmotic pumps filled with either zVAD or carrier and received daily injections
of either streptomycin or saline for 35 d. After the last day of
treatment, the utricles were removed from the ears with the implanted osmotic
pump (ipsilateral), fixed, and processed for immunohistochemistry. After 3 d
of streptomycin treatment, animals that had received zVAD (either 50 or 100
µM) concurrently had significantly more hair cells in both
striolar and extrastriolar regions than control animals
(Table 2). The mean cell counts
for the zVAD/streptomycin-treated utricles were not significantly different
from saline-injected controls (p > 0.5).
After 5 d of streptomycin treatment, more hair cells were present in
zVAD-treated animals (Fig.
1A,C) when compared with either streptomycin alone or
carrier/streptomycin-treated animals (Fig.
1B,C). Treatment with 100 µM zVAD resulted
in nearly full protection, because there was no significant difference in hair
cell density of either sensory region between the saline-treated animals and
100 µM zVAD/streptomycin-treated animals (p > 0.5).
These results suggest that caspase inhibitors promote hair cell survival
during concurrent systemic treatment with streptomycin.
To determine whether zVAD had any direct effects on hair cells, three
additional chickens were implanted with osmotic pumps filled with zVAD, and
three other animals were implanted with pumps filled with carrier and then
allowed to survive for 6 d. The animals were then killed, and the utricles
were removed and processed for calretinin immunohistochemistry. Hair cells
appeared healthy and morphologically normal in all experimental and control
conditions (data not shown). There was no significant difference in hair cell
density between any of the experimental conditions and age-matched nontreated
animals (Fig. 1D)
(p > 0.5).
Systemic injection of zVAD promotes hair cell survival after
streptomycin treatment (experiment series 2)
The previous experiments demonstrated that infusion of zVAD directly into
the inner ear reduced the ototoxic effects of streptomycin. It was also of
interest to determine whether systemic delivery of zVAD would promote hair
cell survival. Animals received daily systemic injections of (1) zVAD (1.5
mg/kg) and streptomycin (1200 mg/kg), (2) streptomycin alone, (3) zVAD alone,
or (4) saline for a total of 5 d. To characterize the pattern of hair cell
loss or protection, the utricular and saccular maculas, along with the
horizontal crista ampularis, were examined for hair cell density. As shown in
Figures 2,
3,
4, little hair cell death
(e.g., fused stereocilia bundles, hair cell "blebbing," or
extruded hair cells) was observed in organs of control animals injected with
saline alone of the horizontal canal (Fig.
2A), the utricle (Fig.
3A), or the saccule
(Fig. 4A). In
contrast, extensive hair cell loss was apparent in the horizontal canal
(Fig. 2C), the utricle
(Fig. 3C), and the
saccule (Fig. 4C) of
animals treated for 5 d with streptomycin. Widespread fusion of stereocilia
bundles was observed in the crista ampullaris of the horizontal canal (data
not shown). In contrast, very little hair cell pathology was observed in
either the utricle or saccular maculas. Instead, stereocilia bundles were
absent from the striolar region of both sensory organs. After 5 d of
concurrent treatment of zVAD and streptomycin, more hair cells were present in
all vestibular organs examined (Figs.
2E,3E,4E),
as compared with streptomycin-alone organs
(Fig. 5). Also, little hair
cell degeneration was observed in stereocilia bundles in any of the organs
after concurrent treatment of zVAD and streptomycin.

View larger version (117K):
[in this window]
[in a new window]
|
Figure 2. Scanning electron micrographs of the horizontal crista ampullaris.
A, Low magnification of the crista from an untreated animal with
numerous hair cells throughout the sensory epithelium. B, High
magnification of the central apical region. C, Low-magnification
image from an animal treated with 5 d of streptomycin (1200 mg/kg) showed that
surviving hair cells were present only at the edge of the epithelium. Hair
cells with mature stereocilia are absent from the central apical region of the
crista (C, D). E, Low-magnification image from an animal
treated with 5 d of zVAD (1.5 mg/kg) and streptomycin. F, Central
apical region of horizontal crista ampullaris shows only moderate hair cell
loss. Scale bars: low magnification, 500 µm; high magnification, 10
µm.
|
|

View larger version (110K):
[in this window]
[in a new window]
|
Figure 3. Scanning electron micrographs of utricles. A, Low-magnification
image of a control utricle with densely populated hair cells. B,
High-magnification image of the striolar region of the same utricle as shown
in A. C, After 5 d of streptomycin treatment, hair cell damage is
predominately localized to the striolar region with extensive stereociliary
loss evident along the entire length of the striola (D). E,
After 5 d of zVAD and streptomycin treatment, some hair cell loss is evident
in the striola, but most hair cells are still present. Scale bars: low
magnification, 500 µm; high magnification, 10 µm.
|
|

View larger version (107K):
[in this window]
[in a new window]
|
Figure 4. Scanning electron micrographs of saccules. A, Low-magnification
image of a control saccule, densely populated by hair cells. B,
High-magnification image of the striolar region of the same saccule as shown
in A. C, After 5 d of streptomycin treatment, hair cell damage is
predominately localized to the striolar region with extensive stereociliary
loss evident along the entire length of the striola (D). E,
After 5 d of zVAD and streptomycin treatment, hair cell loss is evident in the
striolar region (F), but many hair cells are still present when
compared with animals treated with streptomycin alone. Scale bars: low
magnification, 500 µm; high magnification, 10 µm.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Figure 5. Systemic injections of zVAD promote hair cell survival. Chickens were given
daily simultaneous injections of (1) zVAD (1.5 mg/kg) and streptomycin (1200
mg/kg), (2) streptomycin alone, or (3) saline alone for 5 d. Hair cells
(either stereocilia bundles or calretinin + cells) were quantified
in 10,000 µm2 regions from the central region of the horizontal
canal and both the extrastriolar and striolar areas of the utricle. For
stereocilia bundle densities, means (±SD) represent three sampled
regions per organ in the horizontal canal. In the utricle, two regions per
organ of the extrastriolar region and one region per organ in the striolar
region were sampled. For calretinin densities, means (±SD) represent
two regions sampled in each horizontal canal. In the utricle, six regions per
organ in the extrastriolar region and four regions per organ in the striolar
region were sampled. More hair cells were present in both sensory organs after
5 d of treatment of zVAD/streptomycin, when compared with animals receiving
streptomycin alone. Significantly fewer hair cells were present in all sampled
regions of zVAD/streptomycin-treated animals when compared with animals
receiving saline alone (p < 0.01). n = 35
organs.
|
|
Type I hair cells are found predominantly in the central area of the
horizontal canal and the striolar region of the utricle and saccule
(Jørgensen, 1989
;
Si et al., 2003
;
Zakir et al., 2003
). Few
stereociliary bundles remained in either the apical region of the horizontal
canal (Figs. 2D,
5) or the striolar region of
the utricle (Figs. 3D,
5) and saccule
(Fig. 4D) in animals
that received streptomycin alone, suggesting that streptomycin targeted mainly
type I hair cells. In contrast, more stereociliary bundles remained in the
central region of the horizontal canal (Figs.
2F,
5) and the striolar region of
the utricle (Figs. 3F,
5) and saccule
(Fig. 4F) in animals
that received concurrent treatment with zVAD and streptomycin. Interestingly,
the proportional loss of hair cells was greater for the horizontal canal
(Fig. 5), followed by the
saccule (data not shown), followed by the least effect in the utricle
(Fig. 5).
Scanning electron microscopy provides only a "surface" view of
the sensory epithelia, and there may be surviving hair cells present in the
sensory epithelia despite the absence of stereocilia bundles
(Baird et al., 2000
;
Gale et al., 2002
). Therefore,
organs from opposite sides of the same animals were immunolabeled for
calretinin, which identifies hair cells in the avian ear
(Rogers, 1989
;
Matsui et al., 2002a
).
Significantly more hair cells were present in the central region of the
horizontal canal (Fig. 5)
(t(10) = 2.2; p < 0.001) and both the striolar
(t(6) = 2.4; p < 0.05) and extrastriolar
(t(5) = 2.5; p < 0.05) regions of the utricle
(Fig. 5) of
zVAD/streptomycin-treated animals when compared with animals that received
streptomycin alone. Hair cell densities were also obtained from the saccules
of control animals (extrastriolar = 199.7 ± 25.1; striolar = 138
± 16.4). Significant hair cell protection was observed in both the
extrastriolar region (153.9 ± 45.8; t(18) = 2.2;
p < 0.001) and the striolar region (67.1 ± 20.1;
t(14) = 2.2, p < 0.001) of saccules from
zVAD/streptomycin-treated animals when compared with animals that had received
streptomycin alone (extrastriolar = 82.8 ± 27.6; striolar = 32.9
± 8.0).
Unlike direct infusion of zVAD into the vestibule, concurrent systemic
treatment of zVAD with streptomycin did not provide full protection
(Fig. 5). Treatment with zVAD
increased hair cell survival in the central region of the horizontal canal,
when compared with streptomycin alone (difference between streptomycin and
zVAD/streptomycin treatment as a percentage of controls). Additionally,
treatment with zVAD increased hair cell survival in the utricle by 21% in the
extrastriolar region and 43% in the striolar region. Finally, treatment with
zVAD increased hair cell survival in the saccule by 36% in the extrastriolar
region and 25% in the striolar region. As expected, there was no difference in
hair cell densities of any of the organs from animals treated with only zVAD
when compared with control organs (data not shown).
HVOR responses
The previous experiments demonstrated that infusion of zVAD directly into
the inner ear or delivered systemically reduced the ototoxic effects of
streptomycin. It was also of interest to determine whether the surviving hair
cells were functional. In all vertebrates, head motion produces hair cell
responses and compensatory eye movements that function to stabilize visual
gaze (Dickman and Angelaki,
1999
; Dickman et al.,
2000
). To quantify compensatory eye movements resulting from
stimulation of the horizontal canal, animals were rotated around the EVA
(Fig. 6). Normative eye
movements were recorded from 4-week-old animals using eye-search coils, so
that each animal would serve as its own control. As shown in
Figure 7, HVOR responses
consisted primarily of a compensatory horizontal component with no or small
vertical and torsional components. The slow phase gain (horizontal eye
velocity/head velocity) and phase of the elicited horizontal component during
EVA rotation was dependent on stimulus frequency
(Fig. 8). At the lowest
frequency tested (0.01 Hz), the gain of the HVOR response was extremely small
(0.03 ± 0.01), but the gain increased as stimulus frequency increased
from 0.26 ± 0.05 at 0.1 Hz to 0.68 ± 0.14 at 2 Hz. At the higher
stimulus frequencies tested (0.52 Hz), the slow phase gain and phase
values remained relatively constant. In general, the HVOR displayed high-pass
filter characteristics similar to those described in other bird studies
(Carey et al., 1996
;
Dickman et al., 2000
).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 6. Rotation stimulation paradigms for horizontal vestibulo-ocular reflex
(HVOR) and off-vertical axis rotation (OVAR). To stimulate hair cells in the
horizontal canal, the chick was rotated around the EVA at frequencies ranging
from 0.01 to 2 Hz with a constant peak velocity of 20°/sec, except for the
2 Hz stimulus, which was mechanically limited to 10°/sec. Compensatory eye
movements were measured. To stimulate the utricle, OVAR was used to deliver
low- to mid-frequency (0.0.02780.333 Hz) linear acceleration
stimulation with the rotation axis tilted 11.7° (0.2 gm) relative to EVA.
Both clockwise (CW) and counterclockwise (CCW) OVAR rotations were
delivered.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Figure 8. Mean frequency response functions for the HVOR in streptomycin- and
zVAD/streptomycin-treated animals. Mean (±SD) horizontal slow-phase eye
velocity gain and phase values are plotted for control (filled circles),
streptomycin only (open circles; n = 5 animals), and
zVAD/streptomycin (star circles; n = 5 animals) treatment
conditions. Each animal served as its own control. Gain values are presented
as eye velocity/head velocity and phase values as degrees lead relative to
head velocity.
|
|
One day after the normative eye recordings, the animals received daily
systemic injections of (1) zVAD (1.5 mg/kg) and streptomycin (1200 mg/kg), (2)
streptomycin alone, (3) zVAD alone, or (4) saline for a total of 5 d. One day
after the last drug treatment, the eye coils were reattached, and eye
movements were tested again. Chickens treated with streptomycin alone for 5 d
had significantly reduced VOR gains for all stimulus frequencies, as compared
with their pretreatment performance (F(1,7) = 19.2;
p < 0.005). Mean average gains were <0.11 at all frequencies
tested (Fig. 8). The mean HVOR
phase values were significantly advanced at all frequencies tested in the
control measurements, as compared with streptomycin alone
(F(1,7) = 32.0; p < 0.001). A similar loss of
gain and change in phase has been reported previously after a 5 d course of
streptomycin treatment in comparably aged chickens
(Carey et al., 1996
).
Simultaneous treatment with zVAD and streptomycin, however, resulted in
significant protection of HVOR function (F(1,7) = 27.2;
p < 0.005). Mean gain values ranged from 0.15 ± 0.06 at 0.1
Hz to 0.47 ± 0.14 at 2 Hz.
The mean gain values were significantly lower after zVAD/streptomycin
treatment than during their own control runs, suggesting that zVAD provides
incomplete protection (F(1,7) = 27.2; p <
0.001). With the exception of the lowest stimulus frequencies, animals that
received streptomycin alone had significantly smaller phase leads with respect
to head rotations than did animals that had received concurrent treatment with
zVAD and streptomycin (F(1,7) = 24.9; p <
0.005). Animals that were treated simultaneously with zVAD and streptomycin
had similar mean phase responses to control animals in the mid-high
frequencies (0.052 Hz), indicating that the surviving hair cells were
indeed functional (Fig.
8B) (p = 0.3).
zVAD treatment does not impair HVOR measurements
As noted, animals that had received concurrent treatment of zVAD and
streptomycin had gains that were lower than their pretreatment control
performance (Fig. 8). To
determine whether zVAD itself had direct effects on vestibular hair cell
function, two animals were treated with zVAD alone for 5 d. As shown in
Figure 9, zVAD-treated animals
had identical gain (Fig.
9A) and phase (Fig.
9B) values, as compared with their pretreatment control
performance (p > 0.5).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 9. Frequency response functions for the HVOR in animals treated with zVAD
alone. Slow-phase eye velocity gain and phase values are plotted for
pretreatment performance (open symbols) and after 5 d of zVAD treatment
(closed symbols; n = 2 animals). Gain values are presented as eye
velocity/head velocity and phase values as degrees lead relative to head
velocity. Treatment with zVAD had no effect on either the gain or phase.
|
|
OVAR responses
Rotations of the head relative to gravity produce coactivation of both the
semicircular canal and otolith receptors of the vestibular system
(Fig. 6). The utricle and the
saccule are responsible for detecting linear acceleration and head position
with respect to gravity. Otolith-ocular responses during OVAR are elicited in
lateral-eyed species such as rabbits, rats, and pigeons
(Baarsma and Collewijn, 1975
;
Hess and Dieringer, 1990
;
Dickman and Angelaki, 1999
).
Because the rotating gravity stimulus during OVAR is transduced by hair cells,
the viability of the otolithic sensory organs can be estimated by the relative
size of compensatory eye movements during head rotation
(Dickman and Angelaki,
1999
).
During off-vertical axis rotations in normal chickens, eye movement
steady-state responses consisted primarily of sinusoidal modulations of
vertical and torsional components. Similar to other lateral-eyed species, no
horizontal eye movement component was observed
(Hess and Dieringer, 1990
;
Dickman and Angelaki, 1999
;
Maruta et al., 2001
). The
measurements from zVAD/streptomycin-treated animals were compared with those
obtained from animals that were treated only with streptomycin
(Fig. 10). Animals that were
treated with streptomycin alone had significantly lower vertical
(F(1,5) = 9.5; p < 0.05) and torsional
(F(1,6) = 5.4; p < 0.06) component gain values
at low- to midrange frequencies (0.02780.016 Hz), when compared with
their pretreatment performance or zVAD/streptomycin-treated animals.
Surprisingly, streptomycin-treated animals had normal gains at the highest
frequency tested (0.333 Hz; p > 0.05). Simultaneous treatment with
zVAD and streptomycin resulted in slightly lower gains across frequencies, but
these were not significant from their pretreatment performance (p
> 0.5). There was also no phase shift observed in animals treated with
streptomycin (Fig. 10)
(p > 0.3).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 10. Mean (±SD) vertical and torsional slow-phase sensitivity and phase
values to OVAR stimulation as a function of frequency in streptomycin- and
zVAD/streptomycin-treated animals. Mean sensitivity values (degrees per second
divided by gravity) were calculated as slow-phase eye velocity/head
acceleration for four animals. Phase values (degrees) are shown relative to
linear acceleration. Each animal served as its own control.
|
|
 |
Discussion
|
|---|
As shown previously, treatment with the aminoglycoside antibiotic
streptomycin caused a substantial loss of hair cells and a reduction in
vestibular function as measured by the VOR
(Carey et al., 1996
). Animals
that received concurrent administration of streptomycin and the pan-caspase
inhibitor zVAD had significantly more hair cells and better vestibular
function than did animals treated with streptomycin alone. These results
suggest that inhibiting caspase activation during aminoglycoside treatment
results in the rescue of viable hair cells and the preservation of vestibular
function.
Direct infusion of caspase inhibitors promotes vestibular hair cell
survival
Our results demonstrate that direct infusion of zVAD into the labyrinth
dramatically reduced the ototoxic effect of streptomycin, as evidenced by no
observable loss of utricular hair cells. This result is consistent with other
studies in which intracerebroventricular administration of zVAD promoted
neuronal survival in mouse neurodegeneration models
(Ona et al., 1999
;
Li et al., 2000b
) and reduced
the infarct size after transient focal ischemia
(Loddick et al., 1996
). Most
of these studies examined anatomical parameters as opposed to behavioral or
physiological measurements. In one study, however, local application of zVAD
not only reduced apoptotic neuronal death after traumatic spinal chord injury
but also improved behavioral recovery (Li
et al., 2000a
). Other groups have used osmotic pumps to deliver
various drugs to the inner ear, including tetrodotoxin
(Brown et al., 1993
), growth
factors (Miller et al., 1997
;
Kuntz and Oesterle, 1998
;
Ruan et al., 1999
;
Shoji et al., 2000
), and free
radical scavengers (Song and Schacht,
1996
). Although the use of osmotic pumps allows control over the
timing and concentration of drugs applied to the inner ear, the main
disadvantage is that the animal undergoes an invasive surgical procedure,
which may alter inner ear function.
Systemic treatment with zVAD along with an ototoxic agent also provided
partial protection of hair cells, as assessed by morphological evaluation of
hair cells and behavioral responses. Many inner ear disorders can be treated
by systemic administration of drugs (e.g., andrenocorticoid steroids) as a
course of therapy. It is possible that other factors such as affinity for
crossing the bloodbrain barrier or the local titer of zVAD in the inner
ear influenced our findings after systemic treatments. Future studies could
evaluate the effects of increased zVAD dosage on vestibular function and
protection from ototoxic insult. Although hair cell protection from systemic
administration of zVAD was less than that observed after direct application to
the inner ear, the drug did significantly reduce aminoglycoside-induced
ototoxicity.
To quantify the densities of surviving hair cells, we used two different
counting methods: stereocilia bundles versus calretinin-labeled hair cells.
Because stereocilia bundles are necessary for hair cell function,
quantification of calretinin-labeled cells (which also labels the cuticular
plate or the cell body if there is a missing stereocilia bundle) might
overestimate the number of functional surviving hair cells. Although the
trends observed using both counting methods were similar
(Fig. 5), there were almost
twice as many stereocilia bundles in the scanning electron microscopy (SEM)
densities as those observed in the calretinin-labeled tissue. The hair cell
densities obtained from the calretinin labeling were consistent with data
obtained using calretinin and other hair cell markers including hair cell
antigen and lectins (Goodyear et al.,
1999
; Warchol,
2001
; Matsui et al.,
2002a
). The density differences between the two counting methods
could be attributed to the shrinkage that occurs during the dehydration
process when the tissue is prepared for SEM. To estimate shrinkage, the
surface areas from the utricles processed for SEMs were measured. The average
area was 1.026 ± 0.086 mm2, which is
54% smaller than
the surface area of an immunolabeled utricle from comparably aged animals
(Goodyear et al., 1999
). When
we measured the surface areas of the utricles taken from the contralateral ear
(tissue processed for calretinin immunohistochemistry), the SEM-prepared
tissue was 58% smaller than the immunolabeled tissue. When this shrinkage is
taken into consideration, the hair cell densities from the SEM counts are
similar to those in the calretinin-labeled tissue.
Correlation of hair cell density and HVOR/OVAR measurements: are the
hair cells functional?
The HVOR gains measured in chickens before drug treatments were similar to
those observed in other lateral-eyed species. For example, rabbits and pigeons
both have HVOR gains near 0.6 at 1 Hz
(Baarsma and Collewijn, 1975
;
Barmack, 1981
;
Anastasio and Correia, 1988
;
Dickman et al., 2000
), with
phase leading head velocity. At the mid-range stimulus frequencies tested
(0.52 Hz), the leads were generally on the order of 10°. OVAR
steady-state responses measure otolith function and have been demonstrated in
many animal species, including rats, rabbits, monkeys, and pigeons
(Baarsma and Collewijn, 1975
;
Hess and Dieringer, 1990
;
Angelaki and Hess, 1996
;
Dickman and Angelaki, 1999
;
Maruta et al., 2001
). The OVAR
dynamic responses reported here are similar to those reported for pigeons
(Dickman and Angelaki, 1999
).
The spatial phase of the OVAR response in our study was shifted by 90°
relative to the pigeon data because of the difference in the coordinate
reference frame used. For pigeons, phases were expressed relative to the
bird's line of sight, whereas the phases presented here were expressed
relative to the animal's head position.
Five days of streptomycin treatment resulted in substantial hair cell loss
and a greatly reduced vestibular VOR function. The decrease in the VOR
response immediately after streptomycin treatment was directly correlated with
hair cell loss, as determined by hair cell counts from the crista and otolith
organs. Our results demonstrating a reduction in the HVOR response after
streptomycin treatment are similar to those reported previously
(Carey et al., 1996
). In
addition, our data suggest that streptomycin treatment significantly reduces
OVAR responses. Although the reduction in OVAR responses paralleled the HVOR
responses, the reduction in OVAR responses after streptomycin treatment was
not as strong. If hair cell survival were the chief determinant of HVOR/OVAR
gain, then gain would be directly proportional to hair cell density. Carey and
colleagues (1996
) did not find
a strict correlation between hair density and the gain of HVOR. In their
study, the HVOR in the streptomycin-treated animals had gains of <0.1,
although
40% of hair cells were still present. A similar trend was
observed in our data. A measurable response was present after streptomycin
treatment in both studies but was vastly undercompensatory for gaze
stabilization.
Hair cell loss in the saccule was comparable with damage in the horizontal
canal crista. In contrast, much less hair cell loss was evident in the utricle
(Fig. 5). Because the tilt axis
for OVAR stimulation was only 11.5° relative to earth vertical, the
gravitoinnertia acceleration stimulus was acting primarily on utricular hair
cells, because of the geometrical orientation of the maculas. In addition,
correlations between hair cell loss and OVAR reduction suggest that the
utricle and not the saccule was primarily responsible for the observed OVAR
responses, despite the significant loss of saccular hair cells (J. D. Dickman,
unpublished data). One surprising observation was that streptomycin-treated
animals had normal gains at the highest OVAR stimulus-frequency tested (0.333
Hz). At the higher frequencies, perhaps the remaining functional hair cells in
the utricle and saccule were sufficiently stimulated to elicit a normal
gain.
Administration of zVAD along with streptomycin resulted in increased hair
cell survival as well as improved HVOR and OVAR responses. These results
strongly suggest that zVAD has a protective effect on both cell structure and
vestibular function. Systemic injection of zVAD resulted in less hair cell
protection than did direct interlabyrinthine application. Nevertheless, both
cell survival and vestibular compensatory eye-movement gains were
significantly improved when compared with treatment with streptomycin alone.
Several factors may account for reduced vestibular function in
zVAD/streptomycin-treated animals as compared with controls. Aminoglycosides
are known to block the mechanotransduction channel in both auditory and
vestibular hair cells (Ohmori,
1985
; Kimitsuki et al.,
1994
), and the clearance of aminoglycosides from the inner ear
fluids and hair cells requires weeks in mammals
(Aran et al., 1995
). Because
the animals were tested immediately after 5 d of drug therapy, it is possible
that some of the mechanotransduction channels were blocked by streptomycin in
the endolymph, resulting in reduced functional capacity. Functional testing
after the aminoglycosides had been cleared from the inner ear was not feasible
in our study, because chickens readily regenerate their vestibular hair cells
after streptomycin treatment (Weisleder and Rubel,
1992
,
1993
), and regenerated hair
cells are known to restore vestibular function within 13 weeks after
streptomycin treatment (Jones and Nelson,
1992
; Carey et al.,
1996
). It is also possible that streptomycin may have altered the
physiological state of some hair cells. Sympathetic neurons deprived of nerve
growth factor (NGF) in vitro are rescued by application of the
general caspase inhibitor BAF (Deshmukh et
al., 1996
). One study has examined the electrophysiological
properties of NGF-deprived SCG neurons from rats and mice after rescue by BAF
(Werth et al., 2000
). Under
those conditions, NGF deprivation reduced the resting membrane potentials by 9
mV and prolonged action potentials by >50%. To date, there has been no
published study of rescue of sympathetic neurons via caspase inhibitors in
vivo. Comparable reduction in hair cell membrane potentials would lead to
reduced sensitivity to head movements. It is unlikely that the zVAD itself
affected either the HVOR or OVAR because both the gain and phase values in
zVAD-treated animals were identical to control measurements.
In summary, local or systemic administration of the caspase inhibitor zVAD
promotes the survival of functional sensory hair cells in the presence of
toxic insult and may provide a basis for future therapeutic interventions.
 |
Footnotes
|
|---|
Received Feb. 12, 2003;
revised May. 1, 2003;
accepted May. 1, 2003.
This work was supported by The National Organization for Hearing Research
Foundation, the Division of Biology and Biomedical Sciences (Washington
University), and National Institutes of Health (NIH) Individual National
Research Service Award Fellowship F31 DC05082 (J.I.M.). Other funding sources
include Howard Hughes Medical Institute Medical Student Research Fellowship
57003555 (A.H.), the Deafness Research Foundation (D.A.C.), NIH Grant DC02386
(J.D.D.), NIH core facilities Grant P30 DC 04665, NIH Grant DC03576, and
National Aeronautics and Space Administration Grant NAG2-1364 (M.E.W.). We
thank Debbie Corliss and Dr. Petula Coutinho for their excellent surgical
assistance. We thank Dr. Dora Angelaki and Dr. Eugene Johnson Jr for helpful
comments and discussion.
Correspondence should be addressed to either of the following: Mark E.
Warchol, Central Institute for the Deaf, 4560 Clayton Avenue, St. Louis, MO
63110-1549, E-mail:
mwarchol{at}cid.wustl.edu;
or J. David Dickman, Central Institute for the Deaf, 4560 Clayton Avenue, St.
Louis, MO 63110-1549, E-mail:
ddickman{at}cid.wustl.edu.
J. I. Matsui's present address: Harvard University, Department of Molecular
and Cellular Biology, The Biological Laboratories, 16 Divinity Avenue,
Cambridge, MA 02138.
Copyright © 2003 Society for Neuroscience
0270-6474/03/236111-12$15.00/0
 |
References
|
|---|
Anastasio TJ, Correia MJ (1988) A frequency and time
domain study of the horizontal and vertical vestibulo-ocular reflex in the
pigeon. J Neurophysiol 59:
11431161.[Abstract/Free Full Text]
Angelaki DE (1992) Two-dimensional coding of linear
acceleration and the angular velocity sensitivity of the otolith system.
Biol Cybern 67:
511522.[Web of Science][Medline]
Angelaki DE, Hess BJ (1996) Three-dimensional
organization of otolithocular reflexes in rhesus monkeys. I. Linear
acceleration responses during off-vertical axis rotation. J
Neurophysiol 75:
24052424.[Abstract/Free Full Text]
Aran JM, Chappert C, Dulon D, Erre JP, Aurousseau C
(1995) Uptake of amikacin by hair cells of the guinea pig cochlea
and vestibule and ototoxicity: comparison with gentamicin. Hear
Res 82:
179183.[Medline]
Baarsma EA, Collewijn H (1975) Eye movements due to
linear accelerations in the rabbit. J Physiol (Lond)
245:
227249.[Abstract/Free Full Text]
Baird RA, Burton MD, Fashena DS, Naeger RA (2000) Hair
cell recovery in mitotically blocked cultures of the bullfrog saccule.
Proc Natl Acad Sci USA 97:
1172211729.[Abstract/Free Full Text]
Barmack NH (1981) A comparison of the horizontal and
vertical vestibulo-ocular reflexes of the rabbit. J Physiol
(Lond) 314:
547564.[Abstract/Free Full Text]
Brown JN, Miller JM, Altschuler RA, Nuttall AL (1993)
Osmotic pump implant for chronic infusion of drugs into the inner ear.
Hear Res 70:
167172.[Medline]
Carey JP, Fuchs AF, Rubel EW (1996) Hair cell
regeneration and recovery of the vestibuloocular reflex in the avian
vestibular system. J Neurophysiol 76:
33013312.[Abstract/Free Full Text]
Cheng AG, Cunningham LL, Rubel EW (2003) Hair cell
death in the avian basilar papilla: characterization of the in vitro model and
caspase activation. J Assoc Res Otolaryngol
4: 91105.[Medline]
Cunningham LL, Cheng AG, Rubel EW (2002) Caspase
activation in hair cells of the mouse utricle exposed to neomycin. J
Neurosci 22:
85328540.[Abstract/Free Full Text]
Deshmukh M, Vasilakos J, Deckwerth TL, Lampe PA, Shivers BD,
Johnson Jr EM (1996) Genetic and metabolic status of NGF-deprived
sympathetic neurons saved by an inhibitor of ICE family proteases. J
Cell Biol 135:
13411354.[Abstract/Free Full Text]
Dickman JD, Angelaki DE (1999) Three-dimensional
organization of vestibular-related eye movements to off-vertical axis rotation
and linear translation in pigeons. Exp Brain Res
129:
391400.[Web of Science][Medline]
Dickman JD, Beyer M, Hess BJ (2000) Three-dimensional
organization of vestibular related eye movements to rotational motion in
pigeons. Vision Res 40:
28312844.[Web of Science][Medline]
Dye BJ, Frank TC, Newlands SD, Dickman JD (1999)
Distribution and time course of hair cell regeneration in the pigeon utricle.
Hear Res 133:
1726.[Web of Science][Medline]
Forge A (1985) Outer hair cell loss and supporting
cell expansion following chronic gentamicin treatment. Hear Res
19: 171182.[Web of Science][Medline]
Forge A, Li L (2000) Apoptotic death of hair cells in
mammalian vestibular sensory epithelia. Hear Res
139: 97115.[Web of Science][Medline]
Gale JE, Meyers JR, Periasamy A, Corwin JT (2002)
Survival of bundleless hair cells and subsequent bundle replacement in the
bullfrog's saccule. J Neurobiol 50:
8192.[Web of Science][Medline]
Goode CT, Carey JP, Fuchs AF, Rubel EW (1999) Recovery
of the vestibulocolic reflex after aminoglycoside ototoxicity in domestic
chickens. J Neurophysiol 81:
10251035.[Abstract/Free Full Text]
Goode CT, Maney DL, Rubel EW, Fuchs AF (2001) Visual
influences on the development and recovery of the vestibuloocular reflex in
the chicken. J Neurophysiol 85:
11191128.[Abstract/Free Full Text]
Goodyear RJ, Gates R, Lukashkin AN, Richardson GP
(1999) Hair-cell numbers continue to increase in the utricular
macula of the early posthatch chick. J Neurocytol
28: 851861.[Web of Science][Medline]
Haustein W (1989) Considerations on Listing's law and
the primary position by means of a matrix description of eye position control.
Biol Cybern 60:
411420.[Web of Science][Medline]
Hepp K (1990) On Listing's law. Commun Math
Phys 132:
285292.
Hess BJ (1990) Dual-search coil for measuring
3-dimensional eye movements in experimental animals. Vision Res
30: 597602.[Web of Science][Medline]
Hess BJ, Dieringer N (1990) Spatial organization of
the maculo-ocular reflex of the rat: responses during off-vertical axis
rotation. Eur J Neurosci 2:
909919.[Web of Science][Medline]
Hess BJ, Dieringer N (1991) Spatial organization of
linear vestibuloocular reflexes of the rat: responses during horizontal and
vertical linear acceleration. J Neurophysiol
66:
18051818.[Abstract/Free Full Text]
Hinshaw HC, Feldman WH (1945) Streptomycin in
treatment of clinical tuberculosis: a preliminary report. Proc Mayo
Clin 20:
313318.
Jones TA, Nelson RC (1992) Recovery of vestibular
function following hair cell destruction by streptomycin. Hear
Res 62:
181186.[Web of Science][Medline]
Jørgensen JM (1981) On a possible hair cell
turn-over in the inner ear of the caecilian Ichthyophis glutinosus.
Acta Zool 62:
171186.
Jørgensen JM (1989) Number and distribution of
hair cells in the vestibular macula of some avian species. J
Morphol 201:
187204.
Jørgensen JM (1991) Regeneration of lateral
line and inner ear vestibular cells. Ciba Found Symp
160:
151163.[Medline]
Kimitsuki T, Nakagawa T, Hisashi K, Komune S, Uemura T
(1994) The effects of ototoxic drugs on mechano-electric
transduction channels in chick cochlear hair cells. Eur Arch
Otorhinolaryngol 251 [Suppl 1]:
S5356.
Kuntz AL, Oesterle EC (1998) Transforming growth
factor alpha with insulin stimulates cell proliferation in vivo in adult rat
vestibular sensory epithelium. J Comp Neurol
399:
413423.[Web of Science][Medline]
Li L, Nevill G, Forge A (1995) Two modes of hair cell
loss from the vestibular sensory epithelia of the guinea pig inner ear.
J Comp Neurol 355:
405417.[Web of Science][Medline]
Li M, Ona VO, Chen M, Kaul M, Tenneti L, Zhang X, Stieg PE, Lipton
SA, Friedlander RM (2000a) Functional role and therapeutic
implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal
cord injury. Neuroscience 99:
333342.[Web of Science][Medline]
Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ,
Olszewski AJ, Stieg PE, Lee JP, Przedborski S, Friedlander RM
(2000b) Functional role of caspase-1 and caspase-3 in an ALS
transgenic mouse model. Science 288:
335339.[Abstract/Free Full Text]
Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water
TR (1998) Caspase inhibitors prevent cisplatin-induced apoptosis
of auditory sensory cells. NeuroReport
9:
26092614.[Web of Science][Medline]
Loddick SA, MacKenzie A, Rothwell NJ (1996) An ICE
inhibitor, z-VAD DCB attenuates ischaemic brain damage in the rat.
NeuroReport 7:
14651468.[Web of Science][Medline]
Maruta J, Simpson JI, Raphan T, Cohen B (2001)
Orienting otolith-ocular reflexes in the rabbit during static and dynamic
tilts and off-vertical axis rotation. Vision Res
41:
32553270.[Web of Science][Medline]
Matsui JI, Oesterle EC, Stone JS, Rubel EW (2000)
Characterization of damage and regeneration in cultured avian utricles.
J Assoc Res Otolaryngol 1:
4663.[Medline]
Matsui JI, Ogilvie JM, Warchol ME (2002a) Inhibition
of caspases prevents ototoxic and ongoing hair cell death. J
Neurosci 22:
12181227.[Abstract/Free Full Text]
Matsui JI, Messana EP, Alosi JA, Roberson DW, Cotanche DA, Warchol
ME (2002b) Hair cell survival following aminoglycoside treatment
with caspase inhibitors in vivo. Paper presented at the 25th
Annual Midwinter Research meeting of the Association for Research in
Otolaryngology. St. Petersburg, FL, January 2002.
Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA
(1997) Neurotrophins can enhance spiral ganglion cell survival
after inner hair cell loss. Int J Dev Neurosci
15: 631643.[Web of Science][Medline]
Ohmori H (1985) Mechano-electrical transduction
currents in isolated vestibular hair cells of the chick. J Physiol
(Lond) 359:
189217.[Abstract/Free Full Text]
Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS,
Menon AS, Li XJ, Stieg PE, Yuan J, Penney JB, Young AB, Cha JH, Friedlander RM
(1999) Inhibition of caspase-1 slows disease progression in a
mouse model of Huntington's disease. Nature
399:
263267.[Medline]
Raff M (1998) Cell suicide for beginners.
Nature 396:
119122.[Medline]
Roberson DW, Alosi JA, Messana EP, Cotanche DA (2000a)
Effect of violation of the labyrinth on the sensory epithelium in the chick
cochlea. Hear Res 141:
155164.[Medline]
Roberson DW, Alosi JA, Messana EP, Nedder AP, Cotanche DA
(2000b) Endotracheal isoflurane anesthesia for chick auditory
surgery. Hear Res 141:
165168.[Medline]
Robinson DA (1963) A method of measuring eye movements
using a scleral search coil in a magnetic field. IEEE Trans Biomed
Eng 10:
137145.[Medline]
Rogers JH (1989) Two calcium-binding proteins mark
many chick sensory neurons. Neuroscience
31: 697709.[Web of Science][Medline]
Ruan RS, Leong SK, Mark I, Yeoh KH (1999) Effects of
BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin
treatment. NeuroReport 10:
20672071.[Web of Science][Medline]
Salvesen GS, Dixit VM (1997) Caspases: intracellular
signaling by proteolysis. Cell 91:
443446.[Web of Science][Medline]
Shoji F, Yamasoba T, Magal E, Dolan DF, Altschuler RA, Miller JM
(2000) Glial cell line-derived neurotrophic factor has a dose
dependent influence on noise-induced hearing loss in the guinea pig cochlea.
Hear Res 142:
4155.[Medline]
Si X, Zakir M, Dickman JD (2003) Afferent innervation
of the utricular macula in pigeons. J Neurophysiol
89:
16601677.[Abstract/Free Full Text]
Song BB, Schacht J (1996) Variable efficacy of radical
scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea
pig in vivo. Hear Res 94:
8793.[Medline]
Van Optstal J (1993) Representation of eye position in
three dimensions. In: Multisensory control of movement (Berthoz
A, ed), pp 2741. Oxford: Oxford
UP.
Warchol ME (2001) Lectin from Griffonia
simplicifolia identifies an immature-appearing subpopulation of sensory
hair cells in the avian utricle. J Neurocytol
30: 253264.[Medline]
Weisleder P, Rubel EW (1992) Hair cell regeneration in
the avian vestibular epithelium. Exp Neurol
115: 26.[Web of Science][Medline]
Weisleder P, Rubel EW (1993) Hair cell regeneration
after streptomycin toxicity in the avian vestibular epithelium. J Comp
Neurol 331:
97110.[Web of Science][Medline]
Wersäll J (1956) Studies on the structure and
innervation of the sensory epithelium of the cristae ampullaris in the guinea
pig. A light and electron microscopic investigation. Acta
Otolaryngol [Suppl] 126:
185.
Werth JL, Deshmukh M, Cocabo J, Johnson Jr EM, Rothman SM
(2000) Reversible physiological alterations in sympathetic
neurons deprived of NGF but protected from apoptosis by caspase inhibition or
Bax deletion. Exp Neurol 161:
203211.[Web of Science][Medline]
Zakir M, Huss D, Dickman JD (2003) Afferent
innervation patterns of the saccule in pigeons. J Neurophysiol
89: 534550.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
A. Haque, M. Zakir, and J. D. Dickman
Recovery of Gaze Stability During Vestibular Regeneration
J Neurophysiol,
February 1, 2008;
99(2):
853 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Hu and J. T. Corwin
Inner ear hair cells produced in vitro by a mesenchymal-to-epithelial transition
PNAS,
October 16, 2007;
104(42):
16675 - 16680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Haque, D. Huss, and J. D. Dickman
Afferent Innervation Patterns of the Pigeon Horizontal Crista Ampullaris
J Neurophysiol,
December 1, 2006;
96(6):
3293 - 3304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zakir and J. D. Dickman
Regeneration of vestibular otolith afferents after ototoxic damage.
J. Neurosci.,
March 15, 2006;
26(11):
2881 - 2893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dhanireddy, W. C. Liles, and G. A. Gates
Vestibular Toxic Effects Induced by Once-Daily Aminoglycoside Therapy
Arch Otolaryngol Head Neck Surg,
January 1, 2005;
131(1):
46 - 48.
[Full Text]
[PDF]
|
 |
|